This document outlines details of PBS-subsidised mecasermin for patients with severe growth failure with primary insulin-like growth factor-1 deficiency (IGFD).
For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.
Severe growth failure with primary IGFD quick reference
Restrictions |
Authority level and section |
PA assessment |
Processing system |
Prescriber type |
Prescriber self-serve |
Initial
PB336 form
|
Written
Electronic
S100:
mecasermin
|
No
|
OPA
|
Must be treated and prescribed by a:
-
specialist in paediatric endocrinology
-
paediatrician in consultation with a specialist in paediatric endocrinology
|
Yes |
Continuing
PB337 form
|
Written
Electronic
S100:
mecasermin
|
No
|
OPA
|
Must be treated and prescribed by a:
-
specialist in paediatric endocrinology
-
paediatrician in consultation with a specialist in paediatric endocrinology
|
Yes |